RankingsPricing
  1. US-listed companies
  2. MIMEDX GROUP, INC.
  3. Raw

MIMEDX GROUP, INC.MDXG

Market cap
$1B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Net sales------359299248259268321349
Cost of sales------36433943485560
Gross profit--50106167213323256209215220267289
Selling, general and administrative12214690133180259198181198209211225
Research and development335781216111217231312
Investigation, restatement and related-------------9
Amortization of intangible assets1111121111111
Impairment of intangible assets-------110--0
Operating income (loss)-9,761,016-5,355,383-2,638,56772418-4-21-45-5-253759
Interest expense, net-------------1
Other expense, net------10-0-0-0-0-1
Income (loss) from continuing operations before income tax provision----------10-303157
Income tax provision (expense) benefit from continuing operations--99,6141-5627-0-1200-3715
Net income (loss) from continuing operations-----------6742
Income (loss) from discontinued operations, net of tax------------90
Net income (loss)-10,193,986-7,662,376-4,111,85362912-30-26-49-10-305842
Net income (loss) available to common stockholders from continuing operations-----------5642
Continuing operations - basic (in dollars per share)-----------0.480.29
Discontinued operations - basic (in dollars per share)------------0.08-
Basic net income (loss) per common share (in dollars per share)---0.060.280.11-0.28-0.24-0.77-0.15-0.330.40.29
Continuing operations (in dollars per share)-----------0.430.28
Discontinued operations (in dollars per share)------------0.06-
Diluted net income (loss) per common share (in dollars per share)---0.050.260.11-0.28-0.24-0.77-0.15-0.330.370.28